Posts Tagged ‘drugs

March 16, 2020
Our Take: HHS issues finalized data-sharing rules; payers, providers respond with concerns about patient privacy
Read More
March 09, 2020
Our Take: Coronavirus concerns ripple throughout the industry
Read More
March 02, 2020
Our Take: FTC, Pennsylvania challenge proposed merger of Jefferson Health, Albert Einstein Healthcare
Read More
February 24, 2020
Our Take: Private equity firms continue to scoop up physician practices, but at what cost?
Read More
February 17, 2020
Our Take: Insurers report billions in profit, gains in Medicare Advantage enrollment
Read More
February 10, 2020
Our Take: New Humana joint venture will invest $600 million in Medicare-focused primary care clinics
Read More
February 03, 2020
Our Take: New CMS demonstration caps Medicaid funding, allows states to cover fewer drugs and omit some benefits
Read More
September 29, 2019
Our Take: New report shows hospital market concentration growing
Read More
September 23, 2019
Our Take: New report shows hospital market concentration growing
Read More
September 23, 2019
Episode 71: Our Take, September 23, 2019
Read More
September 09, 2019
Our Take: Judge rules against Johnson & Johnson in landmark opioid case
Read More
September 06, 2019
Episode 69: Our Take, September 9, 2019
Read More
August 26, 2019
Episode 68: Our Take, August 26, 2019
Read More
August 12, 2019
Our Take: FDA threatens legal action against Novartis over faulty data used in application for $2.1 million gene therapy
Read More

Sign up for Our Take
the weekly strategic brief for Health Care Executives

share

Reach out to us

Gainey Corporate Center
8777 N Gainey Center Dr, Ste 205
Scottsdale, AZ 85258
(480) 923-0802

Sign up for Our Take
the weekly strategic brief for Health Care Executives

Copyright © 2024 Darwin Research Group Inc.

Stay Connected